1 Market Overview of Alzheimer Disease Treatment 1.1 Alzheimer Disease Treatment Market Overview 1.1.1 Alzheimer Disease Treatment Product Scope 1.1.2 Alzheimer Disease Treatment Market Status and Outlook 1.2 Global Alzheimer Disease Treatment Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Alzheimer Disease Treatment Market Size by Region (2016-2027) 1.4 Global Alzheimer Disease Treatment Historic Market Size by Region (2016-2021) 1.5 Global Alzheimer Disease Treatment Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Alzheimer Disease Treatment Market Size (2016-2027) 1.6.1 North America Alzheimer Disease Treatment Market Size (2016-2027) 1.6.2 Europe Alzheimer Disease Treatment Market Size (2016-2027) 1.6.3 Asia-Pacific Alzheimer Disease Treatment Market Size (2016-2027) 1.6.4 Latin America Alzheimer Disease Treatment Market Size (2016-2027) 1.6.5 Middle East & Africa Alzheimer Disease Treatment Market Size (2016-2027) 2 Alzheimer Disease Treatment Market Overview by Type 2.1 Global Alzheimer Disease Treatment Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global Alzheimer Disease Treatment Historic Market Size by Type (2016-2021) 2.3 Global Alzheimer Disease Treatment Forecasted Market Size by Type (2022-2027) 2.4 Monoamine Oxidase 2.5 Pain Inhibitor (acetylcholinesterase) 2.6 Glutamate Inhibitor 3 Alzheimer Disease Treatment Market Overview by Application 3.1 Global Alzheimer Disease Treatment Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global Alzheimer Disease Treatment Historic Market Size by Application (2016-2021) 3.3 Global Alzheimer Disease Treatment Forecasted Market Size by Application (2022-2027) 3.4 Hospital Pharmacy 3.5 Retail Pharmacy 3.6 Online Sales 4 Alzheimer Disease Treatment Competition Analysis by Players 4.1 Global Alzheimer Disease Treatment Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Alzheimer Disease Treatment as of 2020) 4.3 Date of Key Players Enter into Alzheimer Disease Treatment Market 4.4 Global Top Players Alzheimer Disease Treatment Headquarters and Area Served 4.5 Key Players Alzheimer Disease Treatment Product Solution and Service 4.6 Competitive Status 4.6.1 Alzheimer Disease Treatment Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Allergan 5.1.1 Allergan Profile 5.1.2 Allergan Main Business 5.1.3 Allergan Alzheimer Disease Treatment Products, Services and Solutions 5.1.4 Allergan Alzheimer Disease Treatment Revenue (US$ Million) & (2016-2021) 5.1.5 Allergan Recent Developments 5.2 Eisai 5.2.1 Eisai Profile 5.2.2 Eisai Main Business 5.2.3 Eisai Alzheimer Disease Treatment Products, Services and Solutions 5.2.4 Eisai Alzheimer Disease Treatment Revenue (US$ Million) & (2016-2021) 5.2.5 Eisai Recent Developments 5.3 Novartis 5.5.1 Novartis Profile 5.3.2 Novartis Main Business 5.3.3 Novartis Alzheimer Disease Treatment Products, Services and Solutions 5.3.4 Novartis Alzheimer Disease Treatment Revenue (US$ Million) & (2016-2021) 5.3.5 Teva Pharmaceutical Industries Recent Developments 5.4 Teva Pharmaceutical Industries 5.4.1 Teva Pharmaceutical Industries Profile 5.4.2 Teva Pharmaceutical Industries Main Business 5.4.3 Teva Pharmaceutical Industries Alzheimer Disease Treatment Products, Services and Solutions 5.4.4 Teva Pharmaceutical Industries Alzheimer Disease Treatment Revenue (US$ Million) & (2016-2021) 5.4.5 Teva Pharmaceutical Industries Recent Developments 5.5 Amgen 5.5.1 Amgen Profile 5.5.2 Amgen Main Business 5.5.3 Amgen Alzheimer Disease Treatment Products, Services and Solutions 5.5.4 Amgen Alzheimer Disease Treatment Revenue (US$ Million) & (2016-2021) 5.5.5 Amgen Recent Developments 5.6 Pfizer 5.6.1 Pfizer Profile 5.6.2 Pfizer Main Business 5.6.3 Pfizer Alzheimer Disease Treatment Products, Services and Solutions 5.6.4 Pfizer Alzheimer Disease Treatment Revenue (US$ Million) & (2016-2021) 5.6.5 Pfizer Recent Developments 5.7 UCB 5.7.1 UCB Profile 5.7.2 UCB Main Business 5.7.3 UCB Alzheimer Disease Treatment Products, Services and Solutions 5.7.4 UCB Alzheimer Disease Treatment Revenue (US$ Million) & (2016-2021) 5.7.5 UCB Recent Developments 5.8 H. Lundbeck 5.8.1 H. Lundbeck Profile 5.8.2 H. Lundbeck Main Business 5.8.3 H. Lundbeck Alzheimer Disease Treatment Products, Services and Solutions 5.8.4 H. Lundbeck Alzheimer Disease Treatment Revenue (US$ Million) & (2016-2021) 5.8.5 H. Lundbeck Recent Developments 5.9 F. Hoffmann-La Roche 5.9.1 F. Hoffmann-La Roche Profile 5.9.2 F. Hoffmann-La Roche Main Business 5.9.3 F. Hoffmann-La Roche Alzheimer Disease Treatment Products, Services and Solutions 5.9.4 F. Hoffmann-La Roche Alzheimer Disease Treatment Revenue (US$ Million) & (2016-2021) 5.9.5 F. Hoffmann-La Roche Recent Developments 5.10 Eli Lilly 5.10.1 Eli Lilly Profile 5.10.2 Eli Lilly Main Business 5.10.3 Eli Lilly Alzheimer Disease Treatment Products, Services and Solutions 5.10.4 Eli Lilly Alzheimer Disease Treatment Revenue (US$ Million) & (2016-2021) 5.10.5 Eli Lilly Recent Developments 5.11 Ono Pharmaceutical 5.11.1 Ono Pharmaceutical Profile 5.11.2 Ono Pharmaceutical Main Business 5.11.3 Ono Pharmaceutical Alzheimer Disease Treatment Products, Services and Solutions 5.11.4 Ono Pharmaceutical Alzheimer Disease Treatment Revenue (US$ Million) & (2016-2021) 5.11.5 Ono Pharmaceutical Recent Developments 5.12 Johnson & Johnson 5.12.1 Johnson & Johnson Profile 5.12.2 Johnson & Johnson Main Business 5.12.3 Johnson & Johnson Alzheimer Disease Treatment Products, Services and Solutions 5.12.4 Johnson & Johnson Alzheimer Disease Treatment Revenue (US$ Million) & (2016-2021) 5.12.5 Johnson & Johnson Recent Developments 5.13 Daiichi Sankyo 5.13.1 Daiichi Sankyo Profile 5.13.2 Daiichi Sankyo Main Business 5.13.3 Daiichi Sankyo Alzheimer Disease Treatment Products, Services and Solutions 5.13.4 Daiichi Sankyo Alzheimer Disease Treatment Revenue (US$ Million) & (2016-2021) 5.13.5 Daiichi Sankyo Recent Developments 5.14 Merz Pharma 5.14.1 Merz Pharma Profile 5.14.2 Merz Pharma Main Business 5.14.3 Merz Pharma Alzheimer Disease Treatment Products, Services and Solutions 5.14.4 Merz Pharma Alzheimer Disease Treatment Revenue (US$ Million) & (2016-2021) 5.14.5 Merz Pharma Recent Developments 6 North America 6.1 North America Alzheimer Disease Treatment Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Alzheimer Disease Treatment Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Alzheimer Disease Treatment Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Alzheimer Disease Treatment Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Alzheimer Disease Treatment Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Alzheimer Disease Treatment Market Dynamics 11.1 Alzheimer Disease Treatment Industry Trends 11.2 Alzheimer Disease Treatment Market Drivers 11.3 Alzheimer Disease Treatment Market Challenges 11.4 Alzheimer Disease Treatment Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Alzheimer Disease Treatment Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Alzheimer Disease Treatment Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Alzheimer Disease Treatment Market Size Share by Region (2016-2021) Table 4. Global Alzheimer Disease Treatment Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Alzheimer Disease Treatment Forecasted Market Size Share by Region (2022-2027) Table 6. Global Alzheimer Disease Treatment Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global Alzheimer Disease Treatment Market Size by Type (2016-2021) & (US$ Million) Table 8. Global Alzheimer Disease Treatment Revenue Market Share by Type (2016-2021) Table 9. Global Alzheimer Disease Treatment Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global Alzheimer Disease Treatment Revenue Market Share by Type (2022-2027) Table 11. Global Alzheimer Disease Treatment Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global Alzheimer Disease Treatment Market Size by Application (2016-2021) & (US$ Million) Table 13. Global Alzheimer Disease Treatment Revenue Market Share by Application (2016-2021) Table 14. Global Alzheimer Disease Treatment Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global Alzheimer Disease Treatment Revenue Market Share by Application (2022-2027) Table 16. Global Alzheimer Disease Treatment Revenue (US$ Million) by Players (2016-2021) Table 17. Global Alzheimer Disease Treatment Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Alzheimer Disease Treatment as of 2020) Table 19. Date of Key Manufacturers Enter into Alzheimer Disease Treatment Market Table 20. Global Alzheimer Disease Treatment Top Players Headquarters and Area Served Table 21. Alzheimer Disease Treatment Product Solution and Service Table 22. Global Alzheimer Disease Treatment Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Allergan Basic Information List Table 25. Allergan Description and Business Overview Table 26. Allergan Alzheimer Disease Treatment Products, Services and Solutions Table 27. Revenue (US$ Million) in Alzheimer Disease Treatment Business of Allergan (2016-2021) Table 28. Allergan Recent Developments Table 29. Eisai Basic Information List Table 30. Eisai Description and Business Overview Table 31. Eisai Alzheimer Disease Treatment Products, Services and Solutions Table 32. Revenue (US$ Million) in Alzheimer Disease Treatment Business of Eisai (2016-2021) Table 33. Eisai Recent Developments Table 34. Novartis Basic Information List Table 35. Novartis Description and Business Overview Table 36. Novartis Alzheimer Disease Treatment Products, Services and Solutions Table 37. Revenue (US$ Million) in Alzheimer Disease Treatment Business of Novartis (2016-2021) Table 38. Novartis Recent Developments Table 39. Teva Pharmaceutical Industries Basic Information List Table 40. Teva Pharmaceutical Industries Description and Business Overview Table 41. Teva Pharmaceutical Industries Alzheimer Disease Treatment Products, Services and Solutions Table 42. Revenue (US$ Million) in Alzheimer Disease Treatment Business of Teva Pharmaceutical Industries (2016-2021) Table 43. Teva Pharmaceutical Industries Recent Developments Table 44. Amgen Basic Information List Table 45. Amgen Description and Business Overview Table 46. Amgen Alzheimer Disease Treatment Products, Services and Solutions Table 47. Revenue (US$ Million) in Alzheimer Disease Treatment Business of Amgen (2016-2021) Table 48. Amgen Recent Developments Table 49. Pfizer Basic Information List Table 50. Pfizer Description and Business Overview Table 51. Pfizer Alzheimer Disease Treatment Products, Services and Solutions Table 52. Revenue (US$ Million) in Alzheimer Disease Treatment Business of Pfizer (2016-2021) Table 53. Pfizer Recent Developments Table 54. UCB Basic Information List Table 55. UCB Description and Business Overview Table 56. UCB Alzheimer Disease Treatment Products, Services and Solutions Table 57. Revenue (US$ Million) in Alzheimer Disease Treatment Business of UCB (2016-2021) Table 58. UCB Recent Developments Table 59. H. Lundbeck Basic Information List Table 60. H. Lundbeck Description and Business Overview Table 61. H. Lundbeck Alzheimer Disease Treatment Products, Services and Solutions Table 62. Revenue (US$ Million) in Alzheimer Disease Treatment Business of H. Lundbeck (2016-2021) Table 63. H. Lundbeck Recent Developments Table 64. F. Hoffmann-La Roche Basic Information List Table 65. F. Hoffmann-La Roche Description and Business Overview Table 66. F. Hoffmann-La Roche Alzheimer Disease Treatment Products, Services and Solutions Table 67. Revenue (US$ Million) in Alzheimer Disease Treatment Business of F. Hoffmann-La Roche (2016-2021) Table 68. F. Hoffmann-La Roche Recent Developments Table 69. Eli Lilly Basic Information List Table 70. Eli Lilly Description and Business Overview Table 71. Eli Lilly Alzheimer Disease Treatment Products, Services and Solutions Table 72. Revenue (US$ Million) in Alzheimer Disease Treatment Business of Eli Lilly (2016-2021) Table 73. Eli Lilly Recent Developments Table 74. Ono Pharmaceutical Basic Information List Table 75. Ono Pharmaceutical Description and Business Overview Table 76. Ono Pharmaceutical Alzheimer Disease Treatment Products, Services and Solutions Table 77. Revenue (US$ Million) in Alzheimer Disease Treatment Business of Ono Pharmaceutical (2016-2021) Table 78. Ono Pharmaceutical Recent Developments Table 79. Johnson & Johnson Basic Information List Table 80. Johnson & Johnson Description and Business Overview Table 81. Johnson & Johnson Alzheimer Disease Treatment Products, Services and Solutions Table 82. Revenue (US$ Million) in Alzheimer Disease Treatment Business of Johnson & Johnson (2016-2021) Table 83. Johnson & Johnson Recent Developments Table 84. Daiichi Sankyo Basic Information List Table 85. Daiichi Sankyo Description and Business Overview Table 86. Daiichi Sankyo Alzheimer Disease Treatment Products, Services and Solutions Table 87. Revenue (US$ Million) in Alzheimer Disease Treatment Business of Daiichi Sankyo (2016-2021) Table 88. Daiichi Sankyo Recent Developments Table 89. Merz Pharma Basic Information List Table 90. Merz Pharma Description and Business Overview Table 91. Merz Pharma Alzheimer Disease Treatment Products, Services and Solutions Table 92. Revenue (US$ Million) in Alzheimer Disease Treatment Business of Merz Pharma (2016-2021) Table 93. Merz Pharma Recent Developments Table 94. North America Alzheimer Disease Treatment Market Size by Country (2016-2021) & (US$ Million) Table 95. North America Alzheimer Disease Treatment Market Size by Country (2022-2027) & (US$ Million) Table 96. Europe Alzheimer Disease Treatment Market Size by Country (2016-2021) & (US$ Million) Table 97. Europe Alzheimer Disease Treatment Market Size by Country (2022-2027) & (US$ Million) Table 98. Asia-Pacific Alzheimer Disease Treatment Market Size by Region (2016-2021) & (US$ Million) Table 99. Asia-Pacific Alzheimer Disease Treatment Market Size by Region (2022-2027) & (US$ Million) Table 100. Asia-Pacific Alzheimer Disease Treatment Market Share by Region (2016-2021) Table 101. Asia-Pacific Alzheimer Disease Treatment Market Share by Region (2022-2027) Table 102. Latin America Alzheimer Disease Treatment Market Size by Country (2016-2021) & (US$ Million) Table 103. Latin America Alzheimer Disease Treatment Market Size by Country (2022-2027) & (US$ Million) Table 104. Middle East & Africa Alzheimer Disease Treatment Market Size by Players (2016-2021) & (US$ Million) Table 105. Middle East & Africa Alzheimer Disease Treatment Market Size by Country (2022-2027) & (US$ Million) Table 106. Alzheimer Disease Treatment Market Trends Table 107. Alzheimer Disease Treatment Market Drivers Table 108. Alzheimer Disease Treatment Market Challenges Table 109. Alzheimer Disease Treatment Market Restraints Table 110. Research Programs/Design for This Report Table 111. Key Data Information from Secondary Sources Table 112. Key Data Information from Primary Sources List of Figures Figure 1. Global Alzheimer Disease Treatment Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Alzheimer Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Alzheimer Disease Treatment Market Share by Regions: 2021 VS 2027 Figure 4. Global Alzheimer Disease Treatment Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Alzheimer Disease Treatment Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Alzheimer Disease Treatment Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Alzheimer Disease Treatment Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Alzheimer Disease Treatment Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Alzheimer Disease Treatment Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Alzheimer Disease Treatment Market Size Share by Type in 2021 & 2027 Figure 11. Monoamine Oxidase Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Pain Inhibitor (acetylcholinesterase) Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Glutamate Inhibitor Market Size (US$ Million) YoY Growth (2016-2027) Figure 14. Global Alzheimer Disease Treatment Market Size Share by Application in 2021 & 2027 Figure 15. Hospital Pharmacy Market Size (US$ Million) YoY Growth (2016-2027) Figure 16. Retail Pharmacy Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Online Sales Market Size (US$ Million) YoY Growth (2016-2027) Figure 18. Alzheimer Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 19. Global Top 5 and Top 10 Players Alzheimer Disease Treatment Market Share in 2020 Figure 20. North America Alzheimer Disease Treatment Market Share by Country (2016-2027) Figure 21. United States Alzheimer Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 22. Canada Alzheimer Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 23. Germany Alzheimer Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 24. France Alzheimer Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 25. U.K. Alzheimer Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 26. Italy Alzheimer Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 27. Russia Alzheimer Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 28. Nordic Alzheimer Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 29. Rest of Europe Alzheimer Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 30. Asia-Pacific Alzheimer Disease Treatment Market Share by Region (2016-2027) Figure 31. China Alzheimer Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 32. Japan Alzheimer Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 33. South Korea Alzheimer Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 34. Southeast Asia Alzheimer Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 35. India Alzheimer Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 36. Australia Alzheimer Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 37. Rest of Asia-Pacific Alzheimer Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 38. Latin America Alzheimer Disease Treatment Market Share by Country (2016-2027) Figure 39. Mexico Alzheimer Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 40. Brazil Alzheimer Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 41. Rest of Latin America Alzheimer Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 42. Middle East & Africa Alzheimer Disease Treatment Market Share by Country (2016-2027) Figure 43. Turkey Alzheimer Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 44. Saudi Arabia Alzheimer Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 45. UAE Alzheimer Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 46. Rest of Middle East & Africa Alzheimer Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 47. Bottom-up and Top-down Approaches for This Report Figure 48. Data Triangulation

Allergan Eisai Novartis Teva Pharmaceutical Industries Amgen Pfizer UCB H. Lundbeck F. Hoffmann-La Roche Eli Lilly Ono Pharmaceutical Johnson & Johnson Daiichi Sankyo Merz Pharma